Compare ATRC & PGNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATRC | PGNY |
|---|---|---|
| Founded | 2000 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Misc Health and Biotechnology Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.5B |
| IPO Year | 2005 | 2019 |
| Metric | ATRC | PGNY |
|---|---|---|
| Price | $31.83 | $17.77 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 10 |
| Target Price | ★ $51.17 | $27.60 |
| AVG Volume (30 Days) | 811.4K | ★ 1.5M |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 74.74 | 14.04 |
| EPS | N/A | ★ 0.65 |
| Revenue | $201,630,000.00 | ★ $1,288,661,000.00 |
| Revenue This Year | $14.90 | $10.74 |
| Revenue Next Year | $12.87 | $10.93 |
| P/E Ratio | ★ N/A | $26.60 |
| Revenue Growth | ★ 15.40 | 10.40 |
| 52 Week Low | $28.32 | $16.76 |
| 52 Week High | $43.18 | $28.75 |
| Indicator | ATRC | PGNY |
|---|---|---|
| Relative Strength Index (RSI) | 38.38 | 28.87 |
| Support Level | $30.06 | N/A |
| Resistance Level | $34.59 | $23.73 |
| Average True Range (ATR) | 1.72 | 1.02 |
| MACD | -0.02 | -0.24 |
| Stochastic Oscillator | 47.62 | 18.21 |
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.